|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Levodopa-Induced Dyskinesia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Dyskinesias | |||||
| Parkinson Disease | |||||
| 3 | More general conditions related to this trial | ||||
| Basal Ganglia Diseases | |||||
| Brain Diseases | |||||
| Central Nervous System Diseases | |||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| Neurologic Manifestations | |||||
| Parkinsonian Disorders | |||||
| Signs and Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| Neu-120 | |||||
| 5 | Sponsors listed in this trial | ||||
| Neurim Pharmaceuticals Ltd. | |||||